LTRN
What one share of Lantern Pharma holds
Pharmaceutical Preparations
Lantern Pharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.63 |
|---|---|
| Cash and investments | $0.58 |
| Book value | −$0.25 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$1.23 | — | −$1.08 | — | $0.48 |
| 2020 | — | −$1.37 | — | −$1.31 | — | $3.17 |
| 2021 | — | −$1.13 | $0.00 | −$0.97 | — | $6.45 |
| 2022 | — | −$1.31 | $0.00 | −$1.18 | — | $5.16 |
| 2023 | — | −$1.47 | $0.00 | −$1.32 | — | $3.82 |
| 2024 | — | −$1.93 | $0.00 | −$1.66 | — | $1.96 |
| 2025 | — | −$1.57 | $0.00 | −$1.44 | — | $0.58 |